8-K 1 l93474ae8-k.txt OPTICON MEDICAL, INC. 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: MARCH 22, 2002 OPTICON MEDICAL, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) Delaware 33-17922-C 31-1752868 ------------------------- ---------------------- ------------------------- (STATE OR OTHER (COMMISSION FILE NO.) (IRS EMPLOYER JURISDICTION OF IDENTIFICATION NUMBER) INCORPORATION OR ORGANIZATION) 7001 Post Road Dublin, Ohio 43016 (614) 336-2000 (ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER INCLUDING AREA CODE OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES) Not applicable (FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT) ITEM 5. OTHER EVENTS. On March 22, 2002, Opticon Medical, Inc., a Delaware corporation (the "Company"), issued a press release announcing that the Company had filed a voluntary petition for reorganization under Chapter 11 of the federal Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Ohio, Eastern Division . Additionally, the Company announced that the Company was in discussions with an investor group that may provide the Company with debtor in possession (DIP) financing, and is also interested in purchasing some or all of the Company's assets. The press release dated March 22, 2002 is included as Exhibit 99 to this Form 8-K and is incorporated herein by this reference. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS. (c) EXHIBITS.

2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OPTICON MEDICAL, INC. Date: March 22, 2002 By: /s/ Glenn D. Brunner ------------------------------------ Glenn D. Brunner, President and Chief Executive Officer 3 EXHIBIT INDEX

OPTICON MEDICAL INC 8-K